Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
Clinical trial NCT05387707 · TERMINATED
Trial details
- NCT number
- NCT05387707
- Sponsor
- Cara Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-16
- Primary completion
- 2024-02-02
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.